The loss of p107 or p130, amplification of MYC family members, alterations in the PTEN pathway, and high expression of BCL-2 have all been implicated in promoting cell growth, proliferation, and survival in SCLC. This evidence concerns the gene MYC and small cell lung carcinoma.